Pharma Industry News
Abbott, Medtronic and Stryker YouTube videos fail to include required product warning statements
BOSTON (December 3, 2008) – Pharmaceutical and medical device companies are illegally advertising their products on YouTube, the Prescription...
Analysis: What can we learn from drug marketing efficiency?
LONDON, Dec. 2, 2008-With new drugs being reviewed by regulatory agencies and then released onto the market faster than ever before, patients' safety is being compromised, warns a study...
ROCKVILLE, Md., Dec. 2, 2008--The FDA has posted on its web site questions and answers on ESA medication guides.
Questions and Answers on Medication Guides for Erythropoiesis-Stimulating Agents (ESAs)
Epoetin alfa (marketed as Procrit,...
CHICAGO, Dec. 2, 2008—Contrary to the perception of some patients and physicians, there is no evidence that brand-name drugs are clinically superior to their generic counterparts, according to an article in the December 3 issue of JAMA, which...
ST. PAUL, Minn., Dec. 1, 2008- A new study shows that women who take the epilepsy drug valproate while pregnant may significantly increase their child's risk of developing autism. The preliminary research is published in the December 2, 2008,...
CHICAGO, Nov. 25, 2008—An analysis of randomized trials indicates that use of inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease (COPD) does not improve the rate of survival after one year, but is associated...
SAN MATEO, Calif., November 21, 2008 /PRNewswire/ -- Just three days after the JUPITER trial results were presented at the American Heart Association meeting and simultaneously published online by the New England Journal of Medicine, an AlphaDetail...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 20, 2008 - Targanta Therapeutics Corporation (Nasdaq: TARG) today announced that oritavancin, the Company's investigational antibiotic therapy for the treatment of complicated skin and skin structure infections...
CHICAGO, Nov. 18, 2008—An analysis of randomized controlled trials indicates that use of the cancer drug bevacizumab is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs),...
JERUSALEM--(BUSINESS WIRE)--Nov 19, 2008 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market its...
BETHESDA, Md., Nov. 18, 2008-In contrast to recent findings, two of the most common medications used to treat attention deficit hyperactivity disorder (ADHD) do not appear to cause genetic damage in children who take them as prescribed, according to...
New guideline looks at effectiveness of drugs used to treat depressive disorders
PHILADELPHIA--(BUSINESS WIRE)--No substantial differences in efficacy or quality of life were found among “second-generation” antidepressants used to treat...
Side Effects Examined in First "Real World" Study Since Industry-Sponsored Clinical Trials
SEATTLE--(BUSINESS WIRE)--For smokers interested in quitting tobacco with the use of varenicline (marketed as Chantix), telephone counseling may make it...
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nov 17, 2008 - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that the company has been awarded a $150,000 Small Business Innovation Research (SBIR) grant from the National Institutes of Health...
Washington, Nov. 17, 2008 – The average Medicare beneficiary will spend more out-of-pocket for their health plan premium and drugs in 2009 if they stay in their current standalone drug plan, says new research by Avalere...
WOODCLIFF LAKE, N.J., November 14, 2008/PRNewswire/ --Eisai Corporation of North America announced today that the U.S. Food and Drug Administration (FDA) approved BANZEL(TM) (rufinamide) for the adjunctive treatment of seizures associated with...
ROCKVILLE, Md., Nov. 12, 2008--The U.S. Food and Drug Administration is warning consumers about a fraudulent scheme to extort money from consumers by callers who falsely identify themselves as "FDA special agents" or other FDA officials.
Several...
Update of Safety Review Follow-up to the October 1, 2007
Early Communication about the Ongoing Safety Review of Bisphosphonates
Bisphosphonates: Alendronate (Fosamax, Fosamax Plus D), Etidronate (Didronel), Ibandronate (Boniva), Pamidronate...
Data indicate Focalin XR provides rapid and significant improvements in attention, behavior and academic productivity at 30 minutes post-dose
EAST HANOVER, N.J., November 12, 2008 /PRNewswire/ -- The US Food and Drug Administration (FDA) has...
Proton Pump Inhibitors increase risk of major cardiovascular event by more than 50 percent for patients taking Plavix(R)
FRANKLIN LAKES, N.J., November 11, 2008 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. today presented a study at the...
More...Pharma Industry News Archive
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
